1. Home
  2. PRPO vs JTAI Comparison

PRPO vs JTAI Comparison

Compare PRPO & JTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPO
  • JTAI
  • Stock Information
  • Founded
  • PRPO N/A
  • JTAI 2018
  • Country
  • PRPO United States
  • JTAI United States
  • Employees
  • PRPO N/A
  • JTAI N/A
  • Industry
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • JTAI Blank Checks
  • Sector
  • PRPO Industrials
  • JTAI Finance
  • Exchange
  • PRPO Nasdaq
  • JTAI Nasdaq
  • Market Cap
  • PRPO 8.8M
  • JTAI 9.0M
  • IPO Year
  • PRPO N/A
  • JTAI N/A
  • Fundamental
  • Price
  • PRPO $5.08
  • JTAI $0.37
  • Analyst Decision
  • PRPO
  • JTAI
  • Analyst Count
  • PRPO 0
  • JTAI 0
  • Target Price
  • PRPO N/A
  • JTAI N/A
  • AVG Volume (30 Days)
  • PRPO 9.8K
  • JTAI 358.8K
  • Earning Date
  • PRPO 08-15-2024
  • JTAI 08-15-2024
  • Dividend Yield
  • PRPO N/A
  • JTAI N/A
  • EPS Growth
  • PRPO N/A
  • JTAI N/A
  • EPS
  • PRPO N/A
  • JTAI N/A
  • Revenue
  • PRPO $15,812,000.00
  • JTAI $14,187,646.00
  • Revenue This Year
  • PRPO $75.18
  • JTAI $23.77
  • Revenue Next Year
  • PRPO N/A
  • JTAI $14.43
  • P/E Ratio
  • PRPO N/A
  • JTAI N/A
  • Revenue Growth
  • PRPO 61.64
  • JTAI N/A
  • 52 Week Low
  • PRPO $4.31
  • JTAI $0.25
  • 52 Week High
  • PRPO $8.99
  • JTAI $17.50
  • Technical
  • Relative Strength Index (RSI)
  • PRPO 48.60
  • JTAI 43.84
  • Support Level
  • PRPO $4.32
  • JTAI $0.25
  • Resistance Level
  • PRPO $5.80
  • JTAI $0.37
  • Average True Range (ATR)
  • PRPO 0.43
  • JTAI 0.04
  • MACD
  • PRPO 0.06
  • JTAI 0.01
  • Stochastic Oscillator
  • PRPO 51.68
  • JTAI 92.25

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

About JTAI Jet.AI Inc.

Jet AI Inc is principally involved in the sale of jet cards, which enable holders to use certain aircraft owned, leased by, arranged, and/or managed by Jet Token and others at agreed-upon rates, as well as the sale of fractional interests in aircraft; and the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third party carriers as well as via Jet Token's leased and managed aircraft.

Share on Social Networks: